BioAdaptives (OTC:BDPT) Stock, Quote.Headers.trade-ideas

BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. The Company's current products in development include a weight management supplement in a Human Clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara, PawPa, and MyndMed are also some of its products.

BioAdaptives Inc

Markets

Press Releases

BioAdaptives, Inc. Letter to Shareholders Regarding the Reverse Stock Split

General

BioAdaptives, Inc. Announces Complete Product Overhaul with New Line of Scientifically Advanced Solutions

Health Care

BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace

BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™

News

Dividends

BioAdaptives, Inc.'s Board of Directors Approves a One-for-One Stock Dividend

BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health

BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders

Management

BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors

Comments

BioAdaptives

BioAdaptives (OTC:BDPT) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell